Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Neoplasms
|
609 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 14 | 2004 | 2016 | ||||||
Mammary Neoplasms
|
385 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 12 | 2004 | 2016 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 12 | 2004 | 2014 | ||||||
Breast Carcinoma
|
2793 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||||
Malignant neoplasm of breast
|
3417 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.730 | 1.000 | 3 | 2014 | 2019 | ||||||
Neoplasms
|
1644 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
Liver carcinoma
|
942 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.710 | 1.000 | 2 | 2008 | 2016 | ||||||
ovarian neoplasm
|
757 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 2 | 2005 | 2012 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of prostate
|
108 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Anaplastic Oligodendroglioma
|
4 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Anaplastic Oligodendroglioma
|
7 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Biliary Tract Cancer
|
11 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Brain Neoplasms
|
204 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma
|
103 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
cervical cancer
|
268 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cervix carcinoma
|
283 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Anaplastic Oligodendroglioma
|
4 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Colon Carcinoma
|
275 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Esophageal carcinoma
|
272 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
235 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Glioblastoma
|
281 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
HER2-negative breast cancer
|
18 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
HER2-positive carcinoma of breast
|
26 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Macrodactylia of fingers
|
1 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2016 | 2016 |